Clinical Trial Update: Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy

View source ↗

Summary

This clinical trial update reports the completion of an observational study in Germany evaluating nivolumab in patients with squamous cell carcinoma of the head…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Head and Neck Cancer | Status: COMPLETED